Offerpad (OPAD) Trading Snapshot
- Trading performance (last 24 h): Offerpad closed unchanged at 0 % during the 24‑hour period ending at 10:32 PM Central Europe on Friday, 23 rd.
- Current price: One share is available on major exchanges for approximately USD 2.62.
- Trading volume: In the last 24 hours, roughly USD 68.6 k worth of Offerpad shares were traded.
- Liquidity: The total supply of Offerpad shares is 4.8 million.
- Market capitalization: The company’s market cap stands at USD 11.8 million.
- Historical price range: • 52‑week high: USD 7.05 (recorded 06/05/2026) • 52‑week low: USD 0.57 (recorded 03/30/2026)
- Trend since last month end: Offerpad’s share price has declined -29.39 %.
- Technical indicator: The simple moving average of the last 200 trading days is USD 2.45.
Recent performance of peer stocks
| Stock | Ticker | 24‑h change | Current price | Market cap |
|---|---|---|---|---|
| Tomi Environmental | TOMZ | -0.69 % | USD 1.46 | USD 14.2 million |
| Fgi Industries | FGI | +0.69 % | USD 7.05 | USD 14 million |
| Seastar Medical | ICU | +3.93 % | USD 2.41 | USD 14 million |
| Femasys | FEMY | -1.2 % | USD 1.5 | USD 13.8 million |
| Linkhome | LHAI | +0.12 % | USD 1.05 | USD 13.8 million |
Seastar Medical update
SeaStar Medical Holding Corporation released data from its post‑approval surveillance registry on the QUELIMMUNE therapy for pediatric patients with sepsis‑associated acute kidney injury. The observational study, presented at ASN Kidney Week 2026, showed a statistically significant improvement in 90‑day survival and hospital discharge rates for patients treated with the Selective Cytopheretic Device. No device‑related adverse events were reported. The company states that these real‑world outcomes support the safety profile and potential benefit of the device in this high‑risk population.
Company background
Offerpad Solutions Inc. is a real‑estate development company headquartered in Washington, United States. The company is listed on the New York Stock Exchange.
